Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women: Correlation between oestrogen levels and bone mineral density sites

British Journal of Obstetrics and Gynaecology

Volumn 107, Issue 11, 2000, Pages 1401-1406

  Perry, W ^a   Wiseman, R A ^b  

^a Endocrine Centre   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTRONE; NORETHISTERONE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; FOREARM; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; POSTMENOPAUSE; PRIORITY JOURNAL; TRABECULAR BONE;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE DENSITY; BONE REMODELING; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTRONE; FEMALE; HUMANS; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE; PROGESTERONE CONGENERS; REGRESSION ANALYSIS;

EID: 0033652862     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb11655.x     Document Type: Article

References (13)

1. Women's opinion on withdrawal bleeding with hormone replacement therapy
2. Induced menstruation and cyclical opposed oestrogen replacement therapy: A survey of patient attitudes
3. Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women. 1. Clinical aspects and endometrial histology
4. 17-β oestradiol and continuous norethisterone: A unique treatment for established osteoporosis in elderly women
5. Response of biochemical markers of bone-turnover to hormone replacement therapy: Impact of biological variability
6. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy
7. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study
8. Oestrogen-progestogen replacement therapies in pre- and postmenopausal women - Prevention of osteoporosis
9. Spine and femur density using dual photon absorptiometry in US white women
10. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis
11. Evidence that the progestational agent norethisterone protects against menopausal bone loss
12. Determinates of bone density in normal women: Risk factors for future osteoporosis?
13. Osteoporosis in a largely self-referred population: High prevalence but low medical priority. Why?